Premium
EQUITY OF ACCESS TO INNOVATIVE MEDICINES: MISSION IMPOSSIBLE?
Author(s) -
Attridge Jim
Publication year - 2006
Publication title -
economic affairs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.24
H-Index - 18
eISSN - 1468-0270
pISSN - 0265-0665
DOI - 10.1111/j.1468-0270.2006.00645.x
Subject(s) - equity (law) , biopharmaceutical , context (archaeology) , business , point (geometry) , market access , public economics , economics , industrial organization , political science , geography , microbiology and biotechnology , agriculture , geometry , mathematics , archaeology , law , biology
This paper reviews the literature on the nature of innovation in the biopharmaceutical sector in the context of current approaches to the funding and provision of medicines. From this starting point the paper explores the relationship between market diffusion models, cost containment and equity of access across national populations.